HLB Life Science Co., Ltd. (067630.KQ) KOE
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 472.43B |
| Enterprise Value | 619.49B |
| P/E Ratio | -12.92 |
| PEG Ratio | 0.05 |
| Price/Sales Ratio | 7.87 |
| Price/Book Ratio | 1.52 |
| Enterprise/Revenue | 10.61 |
| Enterprise/EBITDA | -12.66 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.61 |
| Operating Margin | -0.42 |
AD
Management Effectiveness
| Return On Assets | -0.07 |
| Return On Equity | -0.11 |
Income Statement
| Revenue | 45.75B |
| Revenue/Share | 446.46 |
| Gross Profit | -2.04B |
| EBITDA | -15.84B |
| Net Income | -99.85B |
| Diluted EPS | -818.99 |
Balance Sheet
| Total Cash | 10.16B |
| Total Cash/Share | 83.36 |
| Total Debt | 159.25B |
| Total Debt/Equity | 0.56 |
| Current Ratio | 0.58 |
| Book Value Per Share | 2,318.17 |
Price History
| 52-Week Change | -9.17 |
| 52-Week High | 5,330 |
| 52-Week Low | 1,608 |
| Moving Average 50 Days | 3,107.8 |
| Moving Average 200 Days | 3,486.87 |
Statistics
| Average Volume | 608,874 |
| Shares Outstanding | 121.85M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 525849:500000 |
| Last Split Date | December 28, 2022 |
AD
